独一味胶囊联合双氯芬酸钠治疗骨关节炎瘀血阻络证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R684.3;R274.9

基金项目:


Clinical Study on Du Yi Wei Capsules Combined with Diclofenac Sodium in Treating Osteoarthritis with Blood Stasis Blocking Collaterals Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察独一味胶囊联合双氯芬酸钠治疗骨关节炎瘀血阻络证的临床疗效。方法:选取2021年 6月—2023年6月在浙江大学医学院附属金华医院收治的108例骨关节炎瘀血阻络证患者,按随机数字表法分 为对照组及观察组各54例。对照组采用双氯芬酸钠缓释片治疗,观察组在对照组基础上联合独一味胶囊治 疗。2组均持续治疗2周。比较2组临床疗效,比较2组治疗前后疼痛视觉模拟评分法(VAS) 评分、运动功 能[西安大略大学-麦克马斯特大学骨关节炎指数(WOMAC) 评分]、炎性因子[基质金属蛋白酶-3 (MMP-3)、白细胞介素(IL) -6、IL-1β] 及血清疼痛介质[β-内啡肽(β-EP)、P物质(SP) 及前列腺素E2 (PGE2)]。结果:观察组总有效率98.15%(53/54),高于对照组87.04%(47/54)(P<0.05)。2组MPP-3、IL-6、 IL-1β、SP、PGE2、WOMAC 及疼痛VAS 评分均较治疗前降低,观察组MPP-3、IL-6、IL-1β、SP、PGE2、 WOMAC及疼痛VAS评分低于对照组(P<0.05)。2组β-EP均较治疗前升高(P<0.05),观察组β-EP高于对 照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:独一味胶囊联合双氯芬酸 钠缓释片治疗骨关节炎瘀血阻络证疗效好,可减轻炎症反应,缓解疼痛,促进膝关节功能恢复。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Du Yi Wei Capsules combined with Diclofenac Sodium on osteoarthritis with blood stasis blocking collaterals syndrome. Methods: A total of 108 cases of patients with osteoarthritis with blood stasis blocking collaterals syndrome treated at Affiliated Jinhua Hospital,Zhejiang University School of Medicine from June 2021 to June 2023 were selected and divided into the control group and the observation group according to the random number table method,with 54 cases in each group. The control group was treated with Diclofenac Sodium Sustained-Release Tablets, and the observation group was additionally treated with Du Yi Wei Capsules in addition to the treatment given to the control group. Both groups were treated for two weeks continously. Clinical effects were compared between the two groups; Visual Analogue Scale(VAS) scores for pain, Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)scores for physical function,levels of inflammatory factors [matrix metalloproteinase-3(MMP-3), interleukin-6(IL-6), interleukin-1β(IL-1β)], and serum pain mediators [β-endorphin(β-EP),substance P(SP),and prostaglandin E2(PGE2)] in the two groups were compared before and after treatment. Results:The total effective rate was 98.15%(53/54)in the observation group,higher than 87.04%(47/54)in the control group(P<0.05). The levels of MMP-3,IL-6,IL-1β,SP and PGE2,and the scores of WOMAC and VAS in the two groups were decreased when compared with those before treatment,with the observation group showing lower levels and scores than the control group(P<0.05). β-EP levels in the two groups were increased when compared with those before treatment(P<0.05),with the observation group showing higher level than the control group (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05). Conclusion:Du Yi Wei Capsules combined with Diclofenac Sodium has a good curative effect in treating osteoarthritis with blood stasis blocking collaterals syndrome. This combination can reduce inflammation responses, alleviate pain, and promote the recovery of knee joint function.

    参考文献
    相似文献
    引证文献
引用本文

陈伟前,洪鲜花,洪春霞,张超.独一味胶囊联合双氯芬酸钠治疗骨关节炎瘀血阻络证临床研究[J].新中医,2025,57(17):55-59

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-05
  • 出版日期:
文章二维码